The efficacy and safety of a novel PD‐1/CTLA‐4 bispecific antibody cadonilimab (AK104) in advanced non‐small cell lung cancer: A multicenter retrospective observational study. - Li, Hongxin; Zhao, Wen; Li, Chengming; Shen, Hongchang; Li, Meiying; Wang, Chengjun; Han, Chunyan; Yi, Cuihua; Wang, Jun; Meng, Xue; Liu, Lian; Yu, Shuwen; et al. (Thoracic Cancer, 2024)